Canaccord Genuity Downgrades bluebird bio (BLUE) to Hold
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $4.97 --0%
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Canaccord Genuity analyst John Newman downgraded bluebird bio (NASDAQ: BLUE) from Buy to Hold with a price target of $20.00.
For an analyst ratings summary and ratings history on bluebird bio click here. For more ratings news on bluebird bio click here.
Shares of bluebird bio closed at $18.16 yesterday.
You May Also Be Interested In
- HSBC Downgrades Iflytek Co Ltd (002230:CH) to Hold
- Morgan Stanley Downgrades Novo Nordisk (NVO) to Underweight
- Wolfe Research Downgrades Aon Corp (AON) to Underperform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
